Drugsandbrain 003 | 19889A1A109FAE8CC8A8180EA40AD0E587CCF346

Drugsandbrain 003

Name	drugsandbrain-003	DOWNLOAD Copy Link
Total Size	1.8 GB
Total Files	351
Hash	19889A1A109FAE8CC8A8180EA40AD0E587CCF346

/01_2014_Week_1._Organization_and_Overview_2_miniLectures/
01_1._Organization_and_Overview_weeks_1_-_3_11-39.mp4	14.4 MB
01_1._Organization_and_Overview_weeks_1_-_3_11-39.pdf	1.9 MB
01_1._Organization_and_Overview_weeks_1_-_3_11-39.ppt	5.2 MB
01_1._Organization_and_Overview_weeks_1_-_3_11-39.srt	13.3 KB
01_1._Organization_and_Overview_weeks_1_-_3_11-39.txt	8.2 KB
02_2._Organization_and_Overview_weeks_4-_7_9-52.mp4	12.4 MB
02_2._Organization_and_Overview_weeks_4-_7_9-52.pdf	1.9 MB
02_2._Organization_and_Overview_weeks_4-_7_9-52.ppt	5.2 MB
02_2._Organization_and_Overview_weeks_4-_7_9-52.srt	12.0 KB
02_2._Organization_and_Overview_weeks_4-_7_9-52.txt	7.4 KB
/02_2014_Week_1._Introductory_concepts_9_miniLectures/
01_3._What_is_a_Drug_13-44.mp4	47.4 MB
01_3._What_is_a_Drug_13-44.pdf	3.9 MB
01_3._What_is_a_Drug_13-44.ppt	11.3 MB
01_3._What_is_a_Drug_13-44.srt	15.3 KB
01_3._What_is_a_Drug_13-44.txt	9.3 KB
02_4._Drug_Entry_Into_the_Nervous_System_12-52.mp4	14.8 MB
02_4._Drug_Entry_Into_the_Nervous_System_12-52.pdf	3.9 MB
02_4._Drug_Entry_Into_the_Nervous_System_12-52.ppt	11.3 MB
02_4._Drug_Entry_Into_the_Nervous_System_12-52.srt	15.6 KB
02_4._Drug_Entry_Into_the_Nervous_System_12-52.txt	9.6 KB
03_5._Introduction_to_Drug_Receptors_11-55.mp4	13.1 MB
03_5._Introduction_to_Drug_Receptors_11-55.pdf	3.9 MB
03_5._Introduction_to_Drug_Receptors_11-55.ppt	11.3 MB
03_5._Introduction_to_Drug_Receptors_11-55.srt	13.5 KB
03_5._Introduction_to_Drug_Receptors_11-55.txt	8.2 KB
04_6._More_about_receptors_as_proteins_13-22.mp4	16.6 MB
04_6._More_about_receptors_as_proteins_13-22.pdf	3.9 MB
04_6._More_about_receptors_as_proteins_13-22.ppt	11.3 MB
04_6._More_about_receptors_as_proteins_13-22.srt	16.5 KB
04_6._More_about_receptors_as_proteins_13-22.txt	10.1 KB
05_7._Introduction_to_Mammalian_Brains_9-59.mp4	19.3 MB
05_7._Introduction_to_Mammalian_Brains_9-59.pdf	3.9 MB
05_7._Introduction_to_Mammalian_Brains_9-59.ppt	11.3 MB
05_7._Introduction_to_Mammalian_Brains_9-59.srt	12.1 KB
05_7._Introduction_to_Mammalian_Brains_9-59.txt	7.3 KB
06_8._Techniques_for_Studying_the_Brain_10-56.mp4	16.1 MB
06_8._Techniques_for_Studying_the_Brain_10-56.pdf	3.9 MB
06_8._Techniques_for_Studying_the_Brain_10-56.ppt	11.3 MB
06_8._Techniques_for_Studying_the_Brain_10-56.srt	12.2 KB
06_8._Techniques_for_Studying_the_Brain_10-56.txt	7.3 KB
07_9._Botulinum_toxin_9-41.mp4	15.9 MB
07_9._Botulinum_toxin_9-41.pdf	3.9 MB
07_9._Botulinum_toxin_9-41.ppt	11.3 MB
07_9._Botulinum_toxin_9-41.srt	11.2 KB
07_9._Botulinum_toxin_9-41.txt	6.9 KB
08_10._Origin_of_the_Resting_Potential_10-04.mp4	11.5 MB
08_10._Origin_of_the_Resting_Potential_10-04.pdf	3.9 MB
08_10._Origin_of_the_Resting_Potential_10-04.ppt	11.3 MB
08_10._Origin_of_the_Resting_Potential_10-04.srt	12.8 KB
08_10._Origin_of_the_Resting_Potential_10-04.txt	7.7 KB
09_11._Electrical_Aspects_of_Ion_Channels_8-48.mp4	12.7 MB
09_11._Electrical_Aspects_of_Ion_Channels_8-48.pdf	3.9 MB
09_11._Electrical_Aspects_of_Ion_Channels_8-48.ppt	11.3 MB
09_11._Electrical_Aspects_of_Ion_Channels_8-48.srt	10.2 KB
09_11._Electrical_Aspects_of_Ion_Channels_8-48.txt	6.3 KB
/03_2014_Week_2._Dose-response_Relations_3_miniLectures/
01_1__Qualitative_Approaches_9-55.mp4	13.2 MB
01_1__Qualitative_Approaches_9-55.pdf	1.2 MB
01_1__Qualitative_Approaches_9-55.ppt	969.7 KB
01_1__Qualitative_Approaches_9-55.srt	12.5 KB
01_1__Qualitative_Approaches_9-55.txt	7.7 KB
02_2_Quantitative_Approaches_Agonist_Only_10-08.mp4	11.9 MB
02_2_Quantitative_Approaches_Agonist_Only_10-08.pdf	1.2 MB
02_2_Quantitative_Approaches_Agonist_Only_10-08.ppt	969.7 KB
02_2_Quantitative_Approaches_Agonist_Only_10-08.srt	11.9 KB
02_2_Quantitative_Approaches_Agonist_Only_10-08.txt	7.2 KB
03_3_Agonists_plus_Antagonists_7-55.mp4	9.8 MB
03_3_Agonists_plus_Antagonists_7-55.pdf	1.2 MB
03_3_Agonists_plus_Antagonists_7-55.ppt	969.7 KB
03_3_Agonists_plus_Antagonists_7-55.srt	8.8 KB
03_3_Agonists_plus_Antagonists_7-55.txt	5.4 KB
/04_2014_Week_2._Synapses_5_miniLectures/
01_1_The_Synapse_as_a_Drug-Sensitive_Biophysical_Machine_8-08.mp4	12.1 MB
01_1_The_Synapse_as_a_Drug-Sensitive_Biophysical_Machine_8-08.pdf	7.0 MB
01_1_The_Synapse_as_a_Drug-Sensitive_Biophysical_Machine_8-08.ppt	18.4 MB
01_1_The_Synapse_as_a_Drug-Sensitive_Biophysical_Machine_8-08.srt	9.7 KB
01_1_The_Synapse_as_a_Drug-Sensitive_Biophysical_Machine_8-08.txt	6.0 KB
02_2_Nicotinic_Acetylcholine_Receptors-_Activation_10-41.mp4	13.9 MB
02_2_Nicotinic_Acetylcholine_Receptors-_Activation_10-41.pdf	7.0 MB
02_2_Nicotinic_Acetylcholine_Receptors-_Activation_10-41.ppt	18.4 MB
02_2_Nicotinic_Acetylcholine_Receptors-_Activation_10-41.srt	13.1 KB
02_2_Nicotinic_Acetylcholine_Receptors-_Activation_10-41.txt	8.1 KB
03_3_Nicotinic_Acetylcholine_Receptors-_Desensitization_5-14.mp4	5.9 MB
03_3_Nicotinic_Acetylcholine_Receptors-_Desensitization_5-14.pdf	7.0 MB
03_3_Nicotinic_Acetylcholine_Receptors-_Desensitization_5-14.ppt	18.4 MB
03_3_Nicotinic_Acetylcholine_Receptors-_Desensitization_5-14.srt	6.6 KB
03_3_Nicotinic_Acetylcholine_Receptors-_Desensitization_5-14.txt	4.1 KB
04_4_Inhibitory_Ligand-gated_channels_9-51.mp4	13.3 MB
04_4_Inhibitory_Ligand-gated_channels_9-51.pdf	7.0 MB
04_4_Inhibitory_Ligand-gated_channels_9-51.ppt	18.4 MB
04_4_Inhibitory_Ligand-gated_channels_9-51.srt	12.8 KB
04_4_Inhibitory_Ligand-gated_channels_9-51.txt	7.9 KB
05_5_Glutamate-gated_receptor_channels_11-26.mp4	14.6 MB
05_5_Glutamate-gated_receptor_channels_11-26.pdf	7.0 MB
05_5_Glutamate-gated_receptor_channels_11-26.ppt	18.4 MB
05_5_Glutamate-gated_receptor_channels_11-26.srt	14.3 KB
05_5_Glutamate-gated_receptor_channels_11-26.txt	8.8 KB
/05_2014_Week_2._Channel_Blockers_2_miniLectures/
01_1_Pore_Blockers_at_ligand-gated_channels_6-50.mp4	8.5 MB
01_1_Pore_Blockers_at_ligand-gated_channels_6-50.pdf	1.5 MB
01_1_Pore_Blockers_at_ligand-gated_channels_6-50.ppt	6.3 MB
01_1_Pore_Blockers_at_ligand-gated_channels_6-50.srt	7.9 KB
01_1_Pore_Blockers_at_ligand-gated_channels_6-50.txt	5.0 KB
02_2_Voltage-gated_channel_blockers_11-27.mp4	13.8 MB
02_2_Voltage-gated_channel_blockers_11-27.pdf	1.5 MB
02_2_Voltage-gated_channel_blockers_11-27.ppt	6.3 MB
02_2_Voltage-gated_channel_blockers_11-27.srt	14.5 KB
02_2_Voltage-gated_channel_blockers_11-27.txt	8.9 KB
/06_2014_Week_3._G_protein_pathways_5_miniLectures/
01_1_Principles_and_Receptors_13-50.mp4	17.1 MB
01_1_Principles_and_Receptors_13-50.pdf	2.1 MB
01_1_Principles_and_Receptors_13-50.ppt	3.2 MB
01_1_Principles_and_Receptors_13-50.srt	15.9 KB
01_1_Principles_and_Receptors_13-50.txt	9.7 KB
02_2_Inhibitory_G_Proteins_and_their_Effectors_7-10.mp4	11.4 MB
02_2_Inhibitory_G_Proteins_and_their_Effectors_7-10.pdf	2.1 MB
02_2_Inhibitory_G_Proteins_and_their_Effectors_7-10.ppt	3.2 MB
02_2_Inhibitory_G_Proteins_and_their_Effectors_7-10.srt	8.6 KB
02_2_Inhibitory_G_Proteins_and_their_Effectors_7-10.txt	5.3 KB
03_3_The_Stimulatory_G_Protein_Gs_Pathway_11-48.mp4	14.0 MB
03_3_The_Stimulatory_G_Protein_Gs_Pathway_11-48.pdf	2.1 MB
03_3_The_Stimulatory_G_Protein_Gs_Pathway_11-48.ppt	3.2 MB
03_3_The_Stimulatory_G_Protein_Gs_Pathway_11-48.srt	13.1 KB
03_3_The_Stimulatory_G_Protein_Gs_Pathway_11-48.txt	8.1 KB
04_4_The_Ca-mobilizing_G_protein_Gq_pathway__Modifying_G_protein_Pathways_11-13.mp4	14.2 MB
04_4_The_Ca-mobilizing_G_protein_Gq_pathway__Modifying_G_protein_Pathways_11-13.pdf	2.1 MB
04_4_The_Ca-mobilizing_G_protein_Gq_pathway__Modifying_G_protein_Pathways_11-13.ppt	3.2 MB
04_4_The_Ca-mobilizing_G_protein_Gq_pathway__Modifying_G_protein_Pathways_11-13.srt	11.6 KB
04_4_The_Ca-mobilizing_G_protein_Gq_pathway__Modifying_G_protein_Pathways_11-13.txt	6.9 KB
05_5_Outside-in_Mechanisms_for_Long-term_Actions_on_G_Protein_Pathways_12-51.mp4	16.7 MB
05_5_Outside-in_Mechanisms_for_Long-term_Actions_on_G_Protein_Pathways_12-51.pdf	2.1 MB
05_5_Outside-in_Mechanisms_for_Long-term_Actions_on_G_Protein_Pathways_12-51.ppt	3.2 MB
05_5_Outside-in_Mechanisms_for_Long-term_Actions_on_G_Protein_Pathways_12-51.srt	14.0 KB
05_5_Outside-in_Mechanisms_for_Long-term_Actions_on_G_Protein_Pathways_12-51.txt	8.6 KB
/07_2014_Week_3._Neurotransmitter_transporters_2_miniLectures/
01_1_Drugs_Bind_to_Neurotransmitter_Transporters_15-41.mp4	26.3 MB
01_1_Drugs_Bind_to_Neurotransmitter_Transporters_15-41.pdf	1.9 MB
01_1_Drugs_Bind_to_Neurotransmitter_Transporters_15-41.ppt	7.8 MB
01_1_Drugs_Bind_to_Neurotransmitter_Transporters_15-41.srt	18.1 KB
01_1_Drugs_Bind_to_Neurotransmitter_Transporters_15-41.txt	11.1 KB
02_2_Neurotransmitter_Transporters_as_Molecules_11-04.mp4	14.2 MB
02_2_Neurotransmitter_Transporters_as_Molecules_11-04.pdf	1.9 MB
02_2_Neurotransmitter_Transporters_as_Molecules_11-04.ppt	7.8 MB
02_2_Neurotransmitter_Transporters_as_Molecules_11-04.srt	12.5 KB
02_2_Neurotransmitter_Transporters_as_Molecules_11-04.txt	7.7 KB
/08_2014_Week_3._Recreational_Drugs_3_miniLectures/
01_1_Overview_10-56.mp4	13.2 MB
01_1_Overview_10-56.pdf	1.4 MB
01_1_Overview_10-56.ppt	2.1 MB
01_1_Overview_10-56.srt	11.7 KB
01_1_Overview_10-56.txt	7.2 KB
02_2_Targets_8-35.mp4	10.4 MB
02_2_Targets_8-35.pdf	1.4 MB
02_2_Targets_8-35.ppt	2.1 MB
02_2_Targets_8-35.srt	9.7 KB
02_2_Targets_8-35.txt	6.1 KB
03_3_System_level_effects_14-18.mp4	18.0 MB
03_3_System_level_effects_14-18.pdf	1.4 MB
03_3_System_level_effects_14-18.ppt	2.1 MB
03_3_System_level_effects_14-18.srt	16.5 KB
03_3_System_level_effects_14-18.txt	10.3 KB
/09_2014_Week_4._Nicotine_Addiction_5_miniLectures/
01_1_Components_of_addiction._Animal_models_15-13.mp4	16.8 MB
01_1_Components_of_addiction._Animal_models_15-13.pdf	2.7 MB
01_1_Components_of_addiction._Animal_models_15-13.ppt	9.1 MB
01_1_Components_of_addiction._Animal_models_15-13.srt	17.4 KB
01_1_Components_of_addiction._Animal_models_15-13.txt	10.8 KB
02_2_Circuit_and_cellular_level._Outside-In_Mechanisms_11-23.mp4	14.4 MB
02_2_Circuit_and_cellular_level._Outside-In_Mechanisms_11-23.pdf	2.7 MB
02_2_Circuit_and_cellular_level._Outside-In_Mechanisms_11-23.ppt	9.1 MB
02_2_Circuit_and_cellular_level._Outside-In_Mechanisms_11-23.srt	13.5 KB
02_2_Circuit_and_cellular_level._Outside-In_Mechanisms_11-23.txt	8.2 KB
03_3_Circuit_and_Cellular_Level-_Upregulation_via_Inside-Out_Mechanisms_16-34.mp4	21.4 MB
03_3_Circuit_and_Cellular_Level-_Upregulation_via_Inside-Out_Mechanisms_16-34.pdf	2.7 MB
03_3_Circuit_and_Cellular_Level-_Upregulation_via_Inside-Out_Mechanisms_16-34.ppt	9.1 MB
03_3_Circuit_and_Cellular_Level-_Upregulation_via_Inside-Out_Mechanisms_16-34.srt	19.8 KB
03_3_Circuit_and_Cellular_Level-_Upregulation_via_Inside-Out_Mechanisms_16-34.txt	11.9 KB
04_4_Recent_Genetic_Data_13-05.mp4	16.5 MB
04_4_Recent_Genetic_Data_13-05.pdf	2.7 MB
04_4_Recent_Genetic_Data_13-05.ppt	9.1 MB
04_4_Recent_Genetic_Data_13-05.srt	13.9 KB
04_4_Recent_Genetic_Data_13-05.txt	8.4 KB
05_5_Drugs_for_smoking_cessation_Harm_Reduction_14-10.mp4	17.1 MB
05_5_Drugs_for_smoking_cessation_Harm_Reduction_14-10.pdf	2.7 MB
05_5_Drugs_for_smoking_cessation_Harm_Reduction_14-10.ppt	9.1 MB
05_5_Drugs_for_smoking_cessation_Harm_Reduction_14-10.srt	15.5 KB
05_5_Drugs_for_smoking_cessation_Harm_Reduction_14-10.txt	9.6 KB
/10_2014_Week_4._Opiate_Addiction_4_miniLectures/
01_1_Components_of_Opiate_Addiction_10-26.mp4	13.7 MB
01_1_Components_of_Opiate_Addiction_10-26.pdf	1.5 MB
01_1_Components_of_Opiate_Addiction_10-26.ppt	2.5 MB
01_1_Components_of_Opiate_Addiction_10-26.srt	12.1 KB
01_1_Components_of_Opiate_Addiction_10-26.txt	7.3 KB
02_2_Circuits_and_Animal_Models_10-19.mp4	13.4 MB
02_2_Circuits_and_Animal_Models_10-19.pdf	1.5 MB
02_2_Circuits_and_Animal_Models_10-19.ppt	2.5 MB
02_2_Circuits_and_Animal_Models_10-19.srt	11.7 KB
02_2_Circuits_and_Animal_Models_10-19.txt	7.4 KB
03_3_Outside-In_Mechanisms_12-01.mp4	15.5 MB
03_3_Outside-In_Mechanisms_12-01.pdf	1.5 MB
03_3_Outside-In_Mechanisms_12-01.ppt	2.5 MB
03_3_Outside-In_Mechanisms_12-01.srt	14.2 KB
03_3_Outside-In_Mechanisms_12-01.txt	8.8 KB
04_4_Drugs_for_Harm_Reduction_in_Opiate_Addiction_5-23.mp4	6.7 MB
04_4_Drugs_for_Harm_Reduction_in_Opiate_Addiction_5-23.pdf	1.5 MB
04_4_Drugs_for_Harm_Reduction_in_Opiate_Addiction_5-23.ppt	2.5 MB
04_4_Drugs_for_Harm_Reduction_in_Opiate_Addiction_5-23.srt	6.5 KB
04_4_Drugs_for_Harm_Reduction_in_Opiate_Addiction_5-23.txt	4.0 KB
/11_2014_Week_5._Alzheimers_Disease_3_miniLectures/
01_1_Clinical_Description__Genetics_10-48.mp4	13.6 MB
01_1_Clinical_Description__Genetics_10-48.pdf	1.5 MB
01_1_Clinical_Description__Genetics_10-48.ppt	3.2 MB
01_1_Clinical_Description__Genetics_10-48.srt	12.3 KB
01_1_Clinical_Description__Genetics_10-48.txt	7.6 KB
02_2_Pathophysiology_16-12.mp4	19.9 MB
02_2_Pathophysiology_16-12.pdf	1.5 MB
02_2_Pathophysiology_16-12.ppt	3.2 MB
02_2_Pathophysiology_16-12.srt	18.5 KB
02_2_Pathophysiology_16-12.txt	11.5 KB
03_3_Biomarkers__Therapeutic_Approaches_8-58.mp4	10.4 MB
03_3_Biomarkers__Therapeutic_Approaches_8-58.pdf	1.5 MB
03_3_Biomarkers__Therapeutic_Approaches_8-58.ppt	3.2 MB
03_3_Biomarkers__Therapeutic_Approaches_8-58.srt	10.0 KB
03_3_Biomarkers__Therapeutic_Approaches_8-58.txt	6.3 KB
/12_2014_Week_5._Parkinsons_Disease_5_miniLectures/
01_1_Clinical_Picture-_Genetics_12-07.mp4	20.2 MB
01_1_Clinical_Picture-_Genetics_12-07.pdf	6.7 MB
01_1_Clinical_Picture-_Genetics_12-07.ppt	6.1 MB
01_1_Clinical_Picture-_Genetics_12-07.srt	14.5 KB
01_1_Clinical_Picture-_Genetics_12-07.txt	8.8 KB
02_2_Pathophysiology-_Non-human_Models_16-26.mp4	26.3 MB
02_2_Pathophysiology-_Non-human_Models_16-26.pdf	6.7 MB
02_2_Pathophysiology-_Non-human_Models_16-26.ppt	6.1 MB
02_2_Pathophysiology-_Non-human_Models_16-26.srt	19.0 KB
02_2_Pathophysiology-_Non-human_Models_16-26.txt	11.7 KB
03_3_Therapeutic_Approaches-_Symptom_Relief_10-34.mp4	17.5 MB
03_3_Therapeutic_Approaches-_Symptom_Relief_10-34.pdf	6.7 MB
03_3_Therapeutic_Approaches-_Symptom_Relief_10-34.ppt	6.1 MB
03_3_Therapeutic_Approaches-_Symptom_Relief_10-34.srt	12.5 KB
03_3_Therapeutic_Approaches-_Symptom_Relief_10-34.txt	7.8 KB
04_4_Therapeutic_Approaches-_Protection_By_Small_Molecules_17-23.mp4	28.2 MB
04_4_Therapeutic_Approaches-_Protection_By_Small_Molecules_17-23.pdf	6.7 MB
04_4_Therapeutic_Approaches-_Protection_By_Small_Molecules_17-23.ppt	6.1 MB
04_4_Therapeutic_Approaches-_Protection_By_Small_Molecules_17-23.srt	21.4 KB
04_4_Therapeutic_Approaches-_Protection_By_Small_Molecules_17-23.txt	13.1 KB
05_5_Therapeutic_Approaches-_Protection_By_Proteins_or_Gene_Therapy_9-10.mp4	15.2 MB
05_5_Therapeutic_Approaches-_Protection_By_Proteins_or_Gene_Therapy_9-10.pdf	6.7 MB
05_5_Therapeutic_Approaches-_Protection_By_Proteins_or_Gene_Therapy_9-10.ppt	6.1 MB
05_5_Therapeutic_Approaches-_Protection_By_Proteins_or_Gene_Therapy_9-10.srt	10.6 KB
05_5_Therapeutic_Approaches-_Protection_By_Proteins_or_Gene_Therapy_9-10.txt	6.6 KB
/13_2014_Week_6._Pharmacokinetics_and_Metabolism_5_miniLectures/
01_1_Pharmacokinetic_Principles_8-45.mp4	14.3 MB
01_1_Pharmacokinetic_Principles_8-45.pdf	2.4 MB
01_1_Pharmacokinetic_Principles_8-45.ppt	5.2 MB
01_1_Pharmacokinetic_Principles_8-45.srt	10.4 KB
01_1_Pharmacokinetic_Principles_8-45.txt	6.5 KB
02_2_LogP_and_LogD_8-19.mp4	13.3 MB
02_2_LogP_and_LogD_8-19.pdf	2.4 MB
02_2_LogP_and_LogD_8-19.ppt	5.2 MB
02_2_LogP_and_LogD_8-19.srt	9.7 KB
02_2_LogP_and_LogD_8-19.txt	6.1 KB
03_3_Metabolism_and_Breakdown_of_Drugs_10-30.mp4	18.2 MB
03_3_Metabolism_and_Breakdown_of_Drugs_10-30.pdf	2.4 MB
03_3_Metabolism_and_Breakdown_of_Drugs_10-30.ppt	5.2 MB
03_3_Metabolism_and_Breakdown_of_Drugs_10-30.srt	12.0 KB
03_3_Metabolism_and_Breakdown_of_Drugs_10-30.txt	7.4 KB
04_4_Pharmacokinetic_Simulations_6-53.mp4	11.8 MB
04_4_Pharmacokinetic_Simulations_6-53.pdf	2.4 MB
04_4_Pharmacokinetic_Simulations_6-53.ppt	5.2 MB
04_4_Pharmacokinetic_Simulations_6-53.srt	8.1 KB
04_4_Pharmacokinetic_Simulations_6-53.txt	4.9 KB
05_5_Subcellular_Pharmacokinetics_9-35.mp4	17.9 MB
05_5_Subcellular_Pharmacokinetics_9-35.pdf	2.4 MB
05_5_Subcellular_Pharmacokinetics_9-35.ppt	5.2 MB
05_5_Subcellular_Pharmacokinetics_9-35.srt	11.0 KB
05_5_Subcellular_Pharmacokinetics_9-35.txt	6.9 KB
/14_2014_Week_6._Classifying_Psychiatric_Diseases_1_miniLecture/
01_1_Classifying_Psychiatric_Diseases_18-04.mp4	33.5 MB
01_1_Classifying_Psychiatric_Diseases_18-04.pdf	345.6 KB
01_1_Classifying_Psychiatric_Diseases_18-04.ppt	376.8 KB
01_1_Classifying_Psychiatric_Diseases_18-04.srt	20.7 KB
01_1_Classifying_Psychiatric_Diseases_18-04.txt	12.8 KB
/15_2014_Week_6._Anxiety_Disorders_4_miniLectures/
01_1_Definitions_7-19.mp4	12.5 MB
01_1_Definitions_7-19.pdf	5.3 MB
01_1_Definitions_7-19.ppt	5.3 MB
01_1_Definitions_7-19.srt	7.3 KB
01_1_Definitions_7-19.txt	4.4 KB
02_2_The_Amygdala_and_Fear_in_Humans_9-22.mp4	13.5 MB
02_2_The_Amygdala_and_Fear_in_Humans_9-22.pdf	5.3 MB
02_2_The_Amygdala_and_Fear_in_Humans_9-22.ppt	5.3 MB
02_2_The_Amygdala_and_Fear_in_Humans_9-22.srt	10.4 KB
02_2_The_Amygdala_and_Fear_in_Humans_9-22.txt	6.4 KB
03_3_The_Amygdala_and_Fear_in_Animals_11-50.mp4	17.2 MB
03_3_The_Amygdala_and_Fear_in_Animals_11-50.pdf	5.3 MB
03_3_The_Amygdala_and_Fear_in_Animals_11-50.ppt	5.3 MB
03_3_The_Amygdala_and_Fear_in_Animals_11-50.srt	12.7 KB
03_3_The_Amygdala_and_Fear_in_Animals_11-50.txt	7.6 KB
04_4_Drugs_for_Anxiety_8-13.mp4	13.2 MB
04_4_Drugs_for_Anxiety_8-13.pdf	5.3 MB
04_4_Drugs_for_Anxiety_8-13.ppt	5.3 MB
04_4_Drugs_for_Anxiety_8-13.srt	10.0 KB
04_4_Drugs_for_Anxiety_8-13.txt	6.3 KB
/16_2014-_Week_7._Drugs_for_Major_Depressive_Disorder_4_miniLectures/
01_1_Clinical_Description_and_Genetics_13-20.mp4	23.5 MB
01_1_Clinical_Description_and_Genetics_13-20.pdf	7.8 MB
01_1_Clinical_Description_and_Genetics_13-20.ppt	9.7 MB
01_1_Clinical_Description_and_Genetics_13-20.srt	15.7 KB
01_1_Clinical_Description_and_Genetics_13-20.txt	9.6 KB
02_2_Pathophysiology_Animal_Models_Biomarkers_8-50.mp4	14.9 MB
02_2_Pathophysiology_Animal_Models_Biomarkers_8-50.pdf	7.8 MB
02_2_Pathophysiology_Animal_Models_Biomarkers_8-50.ppt	9.7 MB
02_2_Pathophysiology_Animal_Models_Biomarkers_8-50.srt	10.1 KB
02_2_Pathophysiology_Animal_Models_Biomarkers_8-50.txt	6.3 KB
03_3_Mechanisms_of_Antidepressant_Action_10-08.mp4	17.1 MB
03_3_Mechanisms_of_Antidepressant_Action_10-08.pdf	7.8 MB
03_3_Mechanisms_of_Antidepressant_Action_10-08.ppt	9.7 MB
03_3_Mechanisms_of_Antidepressant_Action_10-08.srt	11.0 KB
03_3_Mechanisms_of_Antidepressant_Action_10-08.txt	6.8 KB
04_4_Additional_Antidepressant_Mechanisms_12-06.mp4	20.0 MB
04_4_Additional_Antidepressant_Mechanisms_12-06.pdf	7.8 MB
04_4_Additional_Antidepressant_Mechanisms_12-06.ppt	9.7 MB
04_4_Additional_Antidepressant_Mechanisms_12-06.srt	13.6 KB
04_4_Additional_Antidepressant_Mechanisms_12-06.txt	8.6 KB
/17_2014_Week_7._Drugs_for_Bipolar_Disorder_3_miniLectures/
01_1_Clinical_Description_Genetics_9-40.mp4	16.2 MB
01_1_Clinical_Description_Genetics_9-40.pdf	714.3 KB
01_1_Clinical_Description_Genetics_9-40.ppt	723.0 KB
01_1_Clinical_Description_Genetics_9-40.srt	11.4 KB
01_1_Clinical_Description_Genetics_9-40.txt	6.9 KB
02_2_Heterozygote_Advantage_5-07.mp4	10.6 MB
02_2_Heterozygote_Advantage_5-07.pdf	714.3 KB
02_2_Heterozygote_Advantage_5-07.ppt	723.0 KB
02_2_Heterozygote_Advantage_5-07.srt	6.1 KB
02_2_Heterozygote_Advantage_5-07.txt	3.7 KB
03_3_Drugs_and_Other_Therapies_8-18.mp4	13.1 MB
03_3_Drugs_and_Other_Therapies_8-18.pdf	714.3 KB
03_3_Drugs_and_Other_Therapies_8-18.ppt	723.0 KB
03_3_Drugs_and_Other_Therapies_8-18.srt	9.6 KB
03_3_Drugs_and_Other_Therapies_8-18.txt	5.8 KB
/18_2014_Week_7._Drugs_for_Schizophrenia_4_miniLectures/
01_1_Clinical_Description_Genetics_11-24.mp4	19.9 MB
01_1_Clinical_Description_Genetics_11-24.pdf	6.2 MB
01_1_Clinical_Description_Genetics_11-24.ppt	5.6 MB
01_1_Clinical_Description_Genetics_11-24.srt	12.4 KB
01_1_Clinical_Description_Genetics_11-24.txt	7.6 KB
02_2_Pathophysiology._A_Century_of_Frustration_13-48.mp4	24.4 MB
02_2_Pathophysiology._A_Century_of_Frustration_13-48.pdf	6.2 MB
02_2_Pathophysiology._A_Century_of_Frustration_13-48.ppt	5.6 MB
02_2_Pathophysiology._A_Century_of_Frustration_13-48.srt	15.9 KB
02_2_Pathophysiology._A_Century_of_Frustration_13-48.txt	9.9 KB
03_3_Nongenetic_contributions_Biomarkers__Animal_Models_10-06.mp4	15.4 MB
03_3_Nongenetic_contributions_Biomarkers__Animal_Models_10-06.pdf	6.2 MB
03_3_Nongenetic_contributions_Biomarkers__Animal_Models_10-06.ppt	5.6 MB
03_3_Nongenetic_contributions_Biomarkers__Animal_Models_10-06.srt	11.9 KB
03_3_Nongenetic_contributions_Biomarkers__Animal_Models_10-06.txt	7.3 KB
04_4_Drugs_for_Schizophrenia_8-30.mp4	14.4 MB
04_4_Drugs_for_Schizophrenia_8-30.pdf	6.2 MB
04_4_Drugs_for_Schizophrenia_8-30.ppt	5.6 MB
04_4_Drugs_for_Schizophrenia_8-30.srt	9.4 KB
04_4_Drugs_for_Schizophrenia_8-30.txt	5.8 KB
/19_2014_Week_7._Wrap-Up_1_miniLecture/
01_1_Overview_Summary_Prospects_13-51.mp4	22.6 MB
01_1_Overview_Summary_Prospects_13-51.pdf	2.2 MB
01_1_Overview_Summary_Prospects_13-51.ppt	2.7 MB
01_1_Overview_Summary_Prospects_13-51.srt	16.8 KB
01_1_Overview_Summary_Prospects_13-51.txt	10.2 KB
/
drugsandbrain-003-about.json	6.1 KB
Total files 351